Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group. - Concepedia

Concepedia

Publication | Closed Access

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group.

70

Citations

3

References

1998

Year

D. Schrijvers, Jonas T. Johnson, U Jiminez, M. Gore, P. Kosmidis, H Szpirglas, K. Thomas Robbins, J.O.A.O. Oliveira, Rolf Lewensohn, J. Schüller,

Journal of Clinical Oncology

Abstract

Modulation of CDDP and 5-FU with IFNalpha as used in this study does not improve the RR or the median survival in patients with RMHNC. Patients on both study arms had a poor prognosis, which indicates the need for novel therapies.

References

	Year	Citations

Page 1